Novartis Investigative Site

Kryvyi Rih 50048

0 studies enrolling now · 1 studies all time

What they study most

Neoplasms, Gastrointestinal Tract

Studies at this site

• LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib — Completed